DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
about
Advances in transgenic animal models and techniques.Dyrk1 inhibition improves Alzheimer's disease-like pathology.Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.Inhibition of DYRK1A disrupts neural lineage specification in human pluripotent stem cellsAn ELISA DYRK1A non-radioactive kinase assay suitable for the characterization of inhibitorsRodent models in Down syndrome research: impact and future opportunities.A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy.Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms.Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism.Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.MuvB: A Key to Cell Cycle Control in Ovarian Cancer.DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down SyndromeCorrection of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
P2860
Q38369159-EEA678F2-170D-42F6-A2E9-F78D61F7787DQ41628814-43C183ED-9190-4125-BF0D-6A5754331783Q41696401-AEF70B03-64DA-454A-9201-5AB031C4B7D4Q41918473-556E0B3D-0825-4175-992F-E5CC45597B28Q42327736-88B2671D-A51C-479B-A638-86A5E8B936FCQ46193918-11986A9A-4B6B-47E0-BA33-CC9C9AF87C63Q46250363-0E4723CC-3478-4DAD-8664-F3EA43FF37C2Q47753817-9C95B009-F9DD-4C5E-A485-364B41F3AEB0Q48001145-4962AD56-36C5-49E2-A721-7B9CBEA77911Q50420348-8CC945B6-F27F-44C1-91F5-637A4FE6F34DQ52560273-6E8E232D-BE82-4A59-82E3-B05D108012A0Q54981975-A0850E33-BF31-402E-8ECA-79D32DA19CE8Q55286778-3BA723D5-A694-401D-9037-4E0EA8D41C7EQ58551676-0CACC9E7-0CC3-4432-B5BB-1FE0E8300B74Q59127645-F06FD621-50BE-4AF6-B5E5-4E8BBD8F39F1
P2860
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@ast
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@en
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@nl
type
label
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@ast
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@en
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@nl
prefLabel
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@ast
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@en
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@nl
P2860
P3181
P356
P1476
DYRK1A, a Dosage-Sensitive Gen ...... g Development in Down Syndrome
@en
P2860
P3181
P356
10.3389/FNBEH.2016.00104
P407
P577
2016-01-01T00:00:00Z